Age related macular degeneration (AMD) has been a leading cause of vision loss among older adults for many years. For a long time, treatment for this progressive condition was limited, especially for the dry form. But due to medical advancement and innovative research, macular degeneration treatment is evolving rapidly, with more effective and longer-lasting treatment than ever.
Here, at Dr. Natasha Lim Eye Centre, our goal is to provide our patients with the latest and most advanced therapies. In this article, we’ll explore innovations that are being used in treating Age related macular degeneration. It includes both wet and dry types.
Before we dive further into the new treatment, we have to know the difference between the two.
Both types need a different strategy in treatment. Let us see what is new in both fields.
Wet AMD is a fast-progressing disease and can lead to sudden vision decline if not treated. Formerly, patients have received anti-VEGF shots such as Eylea, Lucentis, Vabysmo, or Avastin, which block the development of new abnormal vessels.
Though these drugs changed the face of macular degeneration therapy, they do include frequent eye injections, often monthly or bi-monthly, exposure, which is draining to all patients.
But things are changing in the future.
Eylea HD is a higher-dose version of the original anti-VEGF treatment. The increased concentration makes longer injection intervals of 3 to 4 months feasible without losing efficacy. For the patient, this means fewer clinic visits and more stable vision protection.
Similarly, Faricimab (Vabysmo) is a new-generation medication that targets two proteins instead of one, VEGF and Ang-2. According to research, it can control symptoms for up to 4 months between doses, delivering better convenience with strong outcomes.
Researchers are out here mixing and matching drugs like they’re making a cocktail. Take OPT-302 (Sozinibercept), this one’s getting tested alongside the usual anti-VEGF meds, hoping to pack a bigger punch and maybe save people from endless eye pokes.
Honestly, if this works out, it could shake up how doctors treat macular degeneration. Fewer needles, longer-lasting results, who wouldn’t want that?
Picture this: you get treated for wet AMD once, and that’s it. Like, no more needles for the rest of your life. Well, gene therapy is inching us closer to that sci-fi dream. Instead of pumping drugs into your eyeball over and over, scientists are working on dropping genes directly into your eye.
They’re trying out two main ways to get those genes in there:
It’s not exactly for everyone, and it’ll probably cost a small fortune at first, but honestly, if this pans out, it’s game-changing for anyone dealing with Age related macular degeneration. Fingers crossed science keeps doing its thing.
Patients with dry Age related macular degeneration, especially those with advanced disease, had very few treatment options until recently. Thankfully, that’s changed.
Researchers have learned that part of the immune system, the complement cascade, can be overactive in dry AMD and cause unnecessary damage to the retina.
Two FDA-approved medications now target this cascade:
They are both given in the eye and work by slowing the progression of geographic atrophy (GA), a severe type of dry AMD. Although these treatment don’t restore lost vision, they cut future vision loss by up to 20%.
You must talk about the risks, side effects, and benefits with your ophthalmologist before starting these treatment.
In more advanced stages of dry macular degeneration, cells in the macula begin to die. Now, researchers are looking to stem cells to replace the lost cells.
Techniques include:
Still in early trials, stem cell therapy represents a new horizon in the treatment of macular degeneration, a potential gateway to restoring vision instead of just slowing its loss. Doctors estimate 10 to 15 years before these become routine, but the foundation is being laid today.
Honestly, it’s kinda wild, macular degeneration treatment isn’t just about keeping things from getting worse anymore. We’re talking about rewiring the whole game. Monthly jabs? Sure, those are still around, but now you’ve got long-lasting options and even gene therapy popping up on the horizon. It’s turning into a whole new world out there.
If you’re here with Dr. Natasha Lim Eye Centre, you’re looking at more customized plans that fit your life, not just some cookie-cutter routine. More comfort, fewer hassles, and way better odds of hanging onto your sight.
The doctors here are always there giving treatment, making sure you get what’s good for you.
Yup! Stuff like Eylea HD and Vabysmo? Already in play at clinics, Dr. Natasha Lim’s included. As for the sci-fi-sounding gene and stem cell tricks, they’re still in the “coming soon” category, but it’s not some distant pipe dream.
Not quite. Most current stuff is about slowing down vision loss, maybe even stopping it. Gene therapy is not magic, but it can help you keep your eyesight and stay in the game for way longer. The “forever fix” thing is still being tested, though, so don’t toss those glasses just yet.
That all depends, honestly. The ideal plan depends on what type and stage of AMD you’ve got going on. The doctors will have a good look (think: eye exam and fancy scans), and then they’ll suggest a treatment plan that’s made for you, not just whatever’s trendy.
If you or someone you love is living with Age related macular degeneration, don’t give up. Treatment are arriving more quickly than ever, promising more options, but improved ones.
Whether it’s extended-release injections, two-action drugs, or cutting-edge therapy like gene and stem cell therapy, the goal is the same: to protect your vision and your independence.
At Dr. Natasha Lim Eye Centre, we strive to offer the newest macular degeneration treatment with compassion and care.
Book your consultation today and discover how these new therapies can help you or your loved one.
Macular degeneration is a progressive retinal condition affecting central vision, and it shows up regularly…
Ophthalmologist Dr Natasha Lim explains how SILK, ICL and other procedures work – and how…
Bladeless cataract surgery is a modern approach that patients can consider, using laser technology to…
Bladeless cataract surgery is a new treatment technique in cataract surgery where the laser technology…
We have seen how cataract surgery can change lives at the Dr. Natasha Lim Eye…
Presbyopia is a normal phenomenon that occurs as a person's lifetime progresses, most commonly after…